Published in Coll Antropol on March 01, 2007
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J (2010) 4.31
Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis (2012) 3.49
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 2.90
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol (2008) 1.88
Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol (2005) 1.66
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil (2010) 1.58
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 1.51
[Vitamin D deficiency in postmenopausal women receiving osteoporosis therapy]. Lijec Vjesn (2008) 1.43
[Less salt--more health. Croatian action on salt and health (CRASH)]. Lijec Vjesn (2009) 1.41
[Omega-3 fatty acids have proven effects on the heart--the impact of GISSI-HF trial]. Lijec Vjesn (2009) 1.39
[Guidelines for diagnostics and treatment of arterial hypertension. Practical recommendations of the Croatian Working Group for Hypertension. Consideration on the ESH-ESC 2007 guidelines]. Lijec Vjesn (2008) 1.37
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis (2007) 1.33
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diab Vasc Dis Res (2008) 1.27
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation (2013) 1.13
Anomalous origin of the left coronary artery from the right sinus of Valsalva in a 62-year-old woman with unstable angina pectoris: a case report. Int J Cardiol (2009) 1.12
Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. J Hypertens (2011) 1.10
Population-level changes to promote cardiovascular health. Eur J Prev Cardiol (2012) 1.00
Dyslipidemias in the prevention of cardiovascular disease: risks and causality. Curr Cardiol Rep (2012) 0.98
Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service. Croat Med J (2005) 0.91
Moraxella lacunata: a rare cause of infective endocarditis. Scand J Infect Dis (2007) 0.91
Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques. Fundam Clin Pharmacol (2012) 0.87
Continental-Mediterranean and rural-urban differences in cardiovascular risk factors in Croatian population. Croat Med J (2011) 0.86
Giant right coronary artery aneurysm. J Cardiovasc Med (Hagerstown) (2011) 0.86
Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics. Psychiatry Res (2011) 0.85
Diabetic dyslipidemia or 'diabetes lipidus'? Expert Rev Cardiovasc Ther (2011) 0.85
Percutaneous coronary intervention of an anomalous right coronary artery originating from the left coronary artery. Wien Klin Wochenschr (2010) 0.85
Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy. Eur J Prev Cardiol (2012) 0.85
Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity. BMC Res Notes (2009) 0.85
Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology. Clin Chem Lab Med (2007) 0.83
Abnormal systolic blood pressure during treadmill test and brachial artery flow-mediated vasodilatation impairment. Coll Antropol (2007) 0.83
Tetralogy of Fallot with cor triatriatum dexter in an adult patient: a case report. Congenit Heart Dis (2012) 0.83
Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Eur J Cardiovasc Prev Rehabil (2006) 0.83
Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project. Eur Heart J (2012) 0.83
Risk factors for microvascular atherosclerotic changes in patients with type 2 diabetes mellitus. Coll Antropol (2013) 0.82
ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study. Coll Antropol (2004) 0.82
[Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?]. Acta Med Croatica (2010) 0.82
Ethylene glycol poisoning. Forensic Sci Int (2007) 0.82
Mitochondrial myopathy associated with a novel 5522G>A mutation in the mitochondrial tRNA(Trp) gene. Eur J Hum Genet (2012) 0.82
Adiponectin level and gene variability are obesity and metabolic syndrome markers in a young population. Arch Med Res (2012) 0.81
Differences in risk factors for coronary heart disease in patients from continental and Mediterranean regions of Croatia. Wien Klin Wochenschr (2008) 0.81
Interactions of MinK and e-NOS gene polymorphisms appear to be inconsistent predictors of atrial fibrillation propensity, but long alleles of ESR1 promoter TA repeat may be a promising marker. Coll Antropol (2009) 0.81
Infective endocarditis of aortic valve during pregnancy: a case report. Int J Cardiol (2007) 0.81
Comorbidity, multimorbidity and personalized psychosomatic medicine: epigenetics rolling on the horizon. Psychiatr Danub (2010) 0.80
Management of overweight and obese patients with coronary heart disease across Europe. Eur J Cardiovasc Prev Rehabil (2010) 0.80
Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits. Coll Antropol (2013) 0.80
New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus? Eur J Cardiovasc Prev Rehabil (2011) 0.79
Clinical study on the effect of simvastatin on paraoxonase activity. Arzneimittelforschung (2007) 0.79
Pulmonary valve papillary fibroelastoma diagnosed by echocardiography: a case report. Eur J Echocardiogr (2009) 0.79
Cytogenetic analysis of azoospermic patients: karyotype comparison of peripheral blood lymphocytes and testicular tissue. Eur J Obstet Gynecol Reprod Biol (2005) 0.78
The prevalence of overweight and obesity among Croatian hospitalized coronary heart disease patients. Coll Antropol (2012) 0.78
Butyrylcholinesterase activity and plasma lipids in dexamethasone treated rats. Acta Pharm (2005) 0.78
Mutation detection in Croatian patients with familial hypercholesterolemia. Ann Hum Genet (2012) 0.78
Mental disorders, treatment response, mortality and serum cholesterol: a new holistic look at old data. Psychiatr Danub (2007) 0.78
Polypill is not a 'vaccine-like' solution for primary cardiovascular disease prevention in all parts of the world. J Epidemiol Community Health (2013) 0.78
Treatment of hypertension by general practitioners and antihypertensive drugs expenditure in an urban environment. Coll Antropol (2009) 0.77
Association of angiotensin-converting enzyme insertion-deletion polymorphism with preeclampsia. Coll Antropol (2008) 0.77
Brugada syndrome unmasked by accidental inhalation of gasoline vapors. Pacing Clin Electrophysiol (2007) 0.77
Acute coronary syndrome frequency in western Herzegovina over the fifteen year period (1987-2001). Coll Antropol (2006) 0.77
The CroHort study: cardiovascular behavioral risk factors in adults, school children and adolescents, hospitalized coronary heart disease patients, and cardio rehabilitation groups in Croatia. Coll Antropol (2012) 0.77
A pilot Croatian survey of risk factor (CRO-SURF) management in patients with cardiovascular disease. Coll Antropol (2012) 0.77
Serotonin transporter polymorphism in Croatian patients with major depressive disorder. Psychiatr Danub (2006) 0.77
Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins. Croat Med J (2004) 0.77
Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor γ. Genet Test Mol Biomarkers (2013) 0.76
Spontaneous perforation of the small intestine, a novel manifestation of classical homocystinuria in an adult with new cystathionine beta-synthetase gene mutations. Coll Antropol (2011) 0.76
The burden of hyperlipidaemia and diabetes in cardiovascular diseases. Fundam Clin Pharmacol (2007) 0.76
[Three-year-old boy--a homozygote for familiar hypercholesterolemia]. Lijec Vjesn (2007) 0.76
[Dietary habits and cardiovascular diseases]. Acta Med Croatica (2010) 0.76
Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis. J Thromb Thrombolysis (2008) 0.76
[Salt--hidden poison in everyday meal]. Lijec Vjesn (2009) 0.76
Estrogen receptor 1 gene (TA)n polymorphism is associated with lone atrial fibrillation in men. Croat Med J (2014) 0.75
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One (2017) 0.75
[European practice guidelines on prevention of cardiovascular diseases: executive summary]. G Ital Cardiol (Rome) (2008) 0.75
Endogenous steroid sex hormones and atherosclerosis of retinal arteries in men. Med Sci Monit (2009) 0.75
[Antianginal and antiadrenergic therapy in acute coronary syndrome]. Acta Med Croatica (2004) 0.75
Statins in heart failure - a failure? Nutr Metab Cardiovasc Dis (2008) 0.75
[Invasive approach to patients with acute coronary syndrome]. Acta Med Croatica (2009) 0.75
[Anti-ischemic therapy in patients with STEMI or NSTEMI treated at county and university hospitals]. Acta Med Croatica (2009) 0.75
[Inflammation markers in acute coronary syndrome]. Acta Med Croatica (2004) 0.75
[Acute coronary syndrome]. Acta Med Croatica (2004) 0.75
[The role of diagnostic work-up at university hospital emergency service and coronary care unit in the management of acute coronary syndrome patients]. Acta Med Croatica (2009) 0.75
A cold shock response triggering acute myocardial infarction. Int J Cardiol (2007) 0.75
[Percutaneous coronary interventions (PTCA and stent) myocardial infarct with ST segment elevation]. Acta Med Croatica (2004) 0.75